Search

Search Constraints

You searched for: Author/Creator Bruix, Jordi

Search Results

2. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Issue 13 (October 2015)

3. Akt‐mediated foxo1 inhibition is required for liver regeneration. Issue 5 (18th December 2015)

5. Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma. Issue 4 (14th October 2020)

7. Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events. Issue 2 (2nd January 2018)

8. Corrigendum to "Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines" [Eur. J. Radiol. 101 (2018) 72–81]. Issue 112 (March 2019)

9. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Issue 101 (April 2018)

10. Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. Issue 6 (6th July 2021)